510(k) Report

PMA · Approved

Approved

Aptima HCV Quant DX Assay

P160023PMAApproved Feb 13, 2017220-day reviewClass II21 CFR 866.3170

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hologic, Inc. · MZP Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

Approved on Feb 13, 2017 through premarket approval, which rests on the device’s own clinical evidence after a 220-day review. 1 later device descends from it.

Decided
Feb 13, 2017
Review
220 days
Class
Class II
Product code
MZP
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2024: 1 descendant cleared201620182020202220242026
  1. This deviceP160023 Aptima HCV Quant DX AssayHologic, Inc. · 2017
  2. Descendant · cites it directly · 0 of its ownK233352 Aptima HCV Quant Dx AssayHologic, Inc. · 2024

Most influential descendants

Showing 1 of 1 · See all
  • K233352Aptima HCV Quant Dx AssayHologic, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)P160023Aptima HCV Quant DX AssayHologic, Inc.2017—
+1K233352Aptima HCV Quant Dx AssayHologic, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of P160023, 2017–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MZP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MZP device

  1. #1 K252484 cobas HCVscore 10.6 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K233352Aptima HCV Quant Dx AssayHologic, Inc.20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K233352 (Hologic, Inc., 2024) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MZP devices

MZP Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · MZP

2in 2025

2007: 52008: 122009: 112010: 192011: 202012: 172013: 242014: 122015: 122016: 212017: 152018: 302019: 352020: 182021: 82022: 12024: 12025: 2
2007high 35 (2019) · low 0 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MZP

Too few MZP 510(k)s in any year since 2007 to give a median.

Recalls per year · MZP

1in 2023

2007: 12011: 22021: 42023: 1
2007high 4 (2021) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MZP

12in 2025

2008: 62009: 122010: 112011: 442012: 262013: 362014: 132015: 12016: 122017: 52018: 42019: 52020: 12021: 12022: 12023: 12024: 22025: 12
2007high 44 (2011) · low 0 (2007)2025

MAUDE reports naming product code MZP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075—10
200812—06
200911—012
201019—011
201120—244
201217—026
201324—036
201412—013
201512—01
201621—012
201715—05
201830—04
201935—05
202018—01
20218—41
20221—01
20230—11
20241—02
20252—012
20260—0—
Cite this page

510(k) Report. “P160023: Aptima HCV Quant DX Assay.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P160023

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026